Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 117, Issue 10, Pages 2740-2750Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI31809
Keywords
-
Categories
Funding
- NCI NIH HHS [NCI P50CA75907, P50 CA070907] Funding Source: Medline
Ask authors/readers for more resources
Lung cancer is the leading cause of cancer death worldwide. The disease is particularly difficult to detect, and patients often present at an advanced stage. Current treatments have limited effectiveness, and unfortunately, the prognosis remains poor. Recent insights into the molecular pathogenesis and biologic behavior of lung cancer have led to the development of rationally designed methods of early detection, prevention, and treatment of this disease. This article will review the important clinical implications of these advances, with a focus on new molecularly targeted therapies currently in development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available